Flavin-containing monooxygenase 3 and human disease.

Expert Opin Drug Metab Toxicol

Human Biomolecular Research Institute, 5310 Eastgate Mall, San Diego, CA 92121, USA.

Published: December 2007

This review summarizes information concerning the association of the human flavin-containing monooxygenase 3 (FMO3) and human diseases. Human FMO3 oxygenates a wide variety of nucleophilic heteroatom-containing xenobiotics, including endogenous substrates and various clinically important drugs. In this article, the authors discuss the association of FMO3 with human disease, including: i) direct association of FMO3 genetic mutations to human genetic disease; ii) association of FMO3 genetic polymorphism to altered drug metabolism and, therefore, indirect association of FMO3 with drug therapeutic efficacy of human disease; and iii) the potential impact and/or effect of FMO3 transcriptional regulation during disease states. Even though many studies discussed for the latter two points are at a preliminary stage and require much more research to bring to a definite conclusion, the authors include these studies to stimulate general interest and invite further discussion.

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.3.6.831DOI Listing

Publication Analysis

Top Keywords

association fmo3
16
human disease
12
flavin-containing monooxygenase
8
fmo3 human
8
fmo3 genetic
8
human
7
fmo3
7
disease
5
association
5
monooxygenase human
4

Similar Publications

Flavin-containing monooxygenases (FMOs) are present in most organisms including plants, fungi, bacteria, invertebrates and vertebrates, where they catalyse the oxidative metabolism of a range of xenobiotics and endogenous metabolites. FMOs have been associated with ageing and longevity in the mouse and in C. elegans.

View Article and Find Full Text PDF

Fecal microbiota transplantation validates the importance of gut microbiota in an ApoE mouse model of chronic apical periodontitis-induced atherosclerosis.

BMC Oral Health

November 2024

Fujian Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research Center of Oral Biomaterial & Stomatology Key lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.

Article Synopsis
  • - This study explores the link between chronic apical periodontitis (CAP) and atherosclerosis, specifically looking at how disruptions in gut microbiota influence this relationship through metabolites like trimethylamine N-oxide (TMAO).
  • - By conducting fecal microbiota transplantation from CAP-affected mice to healthy ones, researchers found that the transplanted mice developed more atherosclerotic lesions despite no significant changes in lipid or inflammatory factors in their serum.
  • - Key findings include an increased ratio of Firmicutes to Bacteroidetes in the gut microbiota of atherosclerosis-affected mice, indicating that specific gut bacteria may play a role in the severity of atherosclerosis linked to CAP, independent of traditional cardiovascular
View Article and Find Full Text PDF

Production of bio-indigo from engineered Pseudomonas putida KT2440 harboring tryptophanase and flavin-containing monooxygenase.

Enzyme Microb Technol

January 2025

Department of Biological Engineering, College of Engineering, Konkuk University, Seoul, Republic of Korea; Institute for Ubiquitous Information Technology and Application, Konkuk University, Seoul, Republic of Korea. Electronic address:

Indigo is a unique blue dye that has been used in the textile industry for centuries and is currently mass-produced commercially through chemical synthesis. However, the use of toxic substrates and reducing agents for chemical synthesis is associated with environmental concerns, necessitating the development of eco-friendly alternatives based on microbial production. In this study, a robust industrial strategy for indigo production was developed using Pseudomonas putida KT2440 as the host strain, which is characterized by its excellent ability to degrade aromatic compounds and high resistance to environmental stress.

View Article and Find Full Text PDF

Deficiency of flavin-containing monooxygenase 3 protects kidney function after ischemia-reperfusion in mice.

Commun Biol

August 2024

Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

The kidney is vulnerable to ischemia and reperfusion (I/R) injury that can be fatal after major surgery. Currently, there are no effective treatments for I/R-induced kidney injury. Trimethylamine N-oxide (TMAO) is a gut-derived metabolite linked to many diseases, but its role in I/R-induced kidney injury remains unclear.

View Article and Find Full Text PDF

Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis.

Mol Med

August 2024

Department of Surgery, Feinberg School of Medicine, Northwestern University, 676 North St. Clair Street, Suite 650, Chicago, IL, 60611, USA.

Background: Tissue fibrosis is a common pathway to failure in many organ systems and is the cellular and molecular driver of myriad chronic diseases that are incompletely understood and lack effective treatment. Recent studies suggest that gut microbe-dependent metabolites might be involved in the initiation and progression of fibrosis in multiple organ systems.

Main Body Of The Manuscript: In a meta-organismal pathway that begins in the gut, gut microbiota convert dietary precursors such as choline, phosphatidylcholine, and L-carnitine into trimethylamine (TMA), which is absorbed and subsequently converted to trimethylamine N-oxide (TMAO) via the host enzyme flavin-containing monooxygenase 3 (FMO3) in the liver.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!